Sort by :
Tumor Tip of the Week- 06-21-2024 Make sure you are recording all treatment -includes treatment done-recommended-refused-contraindicated
Just as important as it is to code the treatment a patient received, you also need to code when a treatment is not given due
-
Omega Healthcare
-
24 June
Tumor Tip of the Week 06-07-2024 Radiation Treatment Volume GYN Brachytherapy after TAHBSO
Scenario: • Endometrioid Adenocarcinoma pT3b pN0 treated with TAH/BSO + XRT • Phase 1 XRT: 2/10/2024 to 3/13/2024, Whole pelvis XRT IMRT/6x, 180 cGy x
-
Omega Healthcare
-
07 June
Tumor Tip of the Week 05-31-2024 Most Specific vs Distinctly Different
Scenario: 2024 Endometrium, curettage: Endometrioid adenocarcinoma, FIGO GR 1 w/ squamous differentiation. TAH/BSO SLN Dissection: Endometrium – Endometrioid adenocarcinoma (FIGO GR 1), confined to the
-
Omega Healthcare
-
03 June
Omega Healthcare Presents Real-World Data Curation Model Helping to Advance Oncology Research
Sessions outline a new hybrid operational model used by Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute to curate structured real-world data for oncology
-
Omega Healthcare
-
30 May
Advancing Oncology Research through Real-World Data Curation: A Collaborative Effort
Author: Heather Grey, SVP/GM of RWD and Clinical Trials, Omega Healthcare At two recent poster sessions co-presented with partners Memorial Sloan Kettering Cancer Center (MSK)
-
Omega Healthcare
-
28 May
Tumor Tip of the Week 5-24-204 Ambiguous Terms on Cytology-Later Confirmed=Date of Diagnosis
Scenario: 5-12-2024 Pleural fluid cytology-Staining pattern is consistent with metastatic carcinoma, most likely of breast origin. 5-15-2024 Oncologist stated the patient had pleural fluid cytology
-
Omega Healthcare
-
27 May